Combined chemotherapy with Shenhong improves the curative effect on metaphase and terminal cancer patients
- VernacularTitle:参红胶囊联合化疗药物提高中晚期肿瘤患者疗效
- Author:
Aiqiang HUANG
;
Haihong YE
;
Shuiting LIANG
;
Shunrong HUANG
;
Biyang LAN
;
Qianzi QIN
- Publication Type:Journal Article
- Keywords:
shenhong capsule(SH);
chemotherapeutic drugs;
curative effect;
Karnofsky grade
- From:
Basic & Clinical Medicine
2006;0(04):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the effects of Shenhong (SH) combined with chemotherapeutic drugs on curative effect, symptoms improvement, and immunology function in metaphase or terminal cancer patients.Methods All 598 patients were divided into two groups. The control group had 205 patients treated with chemotherapeutic drugs. The SH-treated group had 393 patients treated with SH combined with chemotherapeutic drugs. Results Compared with control patients, the total remission was 42.0% in SH-treated patients. The improvement rates of pain, cough, debilitation, and anepithymia were 71.9%. The Karnofsky grade was increased by 27.0%. CD+3 and CD+4 were increased by 11.6% and 19.3%, but CD+8was decreased by 22.6% at the same time. The patients CD+4 / CD+8 was enhanced by 54.2%, while the NK cell activity and marophage phagocysis were significantly improved. The content of Ig G and Ig A were increased in the same group. Conclusion The curative effect of SH combined with chemotherapeutic drugs was higher than that of control group. The therapeutic effect of SH is explained by its potential regulation activity on immun system.
